<< Prev  2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next >>

Guide on Device Quality Improvement Program 05/09/2022

Draft Guide on Testosterone ANDA Bioequivalence 05/09/2022

Toxic Risk with Fresenius Hemodialysis Machines: FDA 05/06/2022

Info Collection on Investigational Device Exemptions 05/06/2022

Device Guidance on Voluntary Improvement Program 05/06/2022

Myovant, Pfizer Myfembree sNDA Review Extended 05/06/2022

Diabetes Device Feasibility Studies Guidance 05/06/2022

Increase FDA Oversight of Lab-developed Tests: Pew 05/06/2022

Califf Returned to FDA for ‘Unfinished Business’ 05/06/2022

Lasik Injury Advocate Steps Up Pressure on ‘Illegal Ads’ 05/06/2022

<< Prev  2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21  Next >>